There are currently 1983 clinical trials in Chicago, Illinois looking for participants to engage in research studies. Trials are conducted at various facilities, including Northwestern University, Rush University Medical Center, University of Chicago and University of Chicago Comprehensive Cancer Center. Whether you're a healthy volunteer looking to participate in paid medical research or seeking trials related to a specific condition, the city provides a diverse range of opportunities near you.
Convalescent Plasma as a Possible Treatment for COVID-19
NCT04442191
Recruiting
Patients who are ill with COVID-19 may benefit from receiving convalescent plasma infusions containing antibodies from donors who have recovered from the disease and are proven to no longer be infected. Given the current public health emergency due to COVID-19, the FDA has recently fast-tracked the use of convalescent plasma. The purpose for this study is to assess if convalescent plasma collected from donors previously infected with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2),... Read More
Gender:
ALL
Ages:
40 years and above
Trial Updated:
06/19/2020
Locations: University of Illinois at Chicago, Chicago, Illinois
Conditions: COVID-19
Register for Updates
Safety and Efficacy Study of OMS721 in Patients With Atypical Hemolytic Uremic Syndrome
NCT03205995
Recruiting
The purpose of this study is to evaluate the platelet count change from baseline and safety of OMS721 in adults and adolescents with atypical hemolytic uremic syndrome (aHUS). The study will also evaluate pharmacokinetics (PK), pharmacodynamics (PD), and anti-drug antibody response (ADA).
Gender:
ALL
Ages:
12 years and above
Trial Updated:
10/17/2018
Locations: Omeros Investigational Site, Chicago, Illinois
Conditions: Thrombotic Microangiopathies, Atypical Hemolytic Uremic Syndrome
Register for Updates
Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital Toxoplasmosis
NCT00004317
Recruiting
RATIONALE: Congenital toxoplasmosis is an infection caused by the parasitic organism Toxoplasma gondii, and it may be passed from an infected mother to her unborn child. The mother may have mild symptoms or no symptoms; the fetus, however, may experience damage to the eyes, nervous system, skin, and ears. The newborn may have a low birth weight, enlarged liver and spleen, jaundice, anemia, petechiae, and eye damage. Giving the antiparasitic drugs pyrimethamine and sulfadiazine is standard treatm... Read More
Gender:
ALL
Ages:
All
Trial Updated:
05/13/2009
Locations: University of Chicago, Chicago, Illinois
Conditions: Toxoplasmosis
Register for Updates